Literature DB >> 9518149

Identification of adenine nucleotide-containing metabolites of bisphosphonate drugs using ion-pair liquid chromatography-electrospray mass spectrometry.

S Auriola1, J Frith, M J Rogers, A Koivuniemi, J Mönkkönen.   

Abstract

Bisphosphonates are synthetic pyrophosphate analogues, which are used as therapeutic drugs for the treatment of metabolic bone disorders. Some of these bisphosphonates can be metabolised in cells into non-hydrolysable nucleotide analogues. In this paper, we describe an ion-pairing high-performance liquid chromatography method that is compatible with negative ion electrospray mass spectrometry for the separation of these metabolites. Tandem mass spectrometry and collision-induced dissociation (CID) were used for identification of the metabolites. The CID mass spectra of bisphosphonate-adenine nucleotide adducts are very informative, because major fragment ions are formed by cleavage of the bisphosphonate moiety from the conjugate. The method was used for detection of the nucleotide metabolites of clodronate, tiludronate and etidronate in extracts from mammalian cells after treatment with bisphosphonates.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9518149     DOI: 10.1016/s0378-4347(97)00490-8

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  16 in total

1.  Zoledronic acid induces formation of a pro-apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF-7 cells in vitro.

Authors:  Johanna Räikkönen; Julie C Crockett; Michael J Rogers; Hannu Mönkkönen; Seppo Auriola; Jukka Mönkkönen
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

2.  The cellular uptake and metabolism of clodronate in RAW 264 macrophages.

Authors:  H Mönkkönen; M J Rogers; N Makkonen; S Niva; S Auriola; J Mönkkönen
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

3.  Clodronate exerts an anabolic effect on articular chondrocytes mediated through the purinergic receptor pathway.

Authors:  R G Rosa; K Collavino; A Lakhani; E Delve; J F Weber; A K Rosenthal; S D Waldman
Journal:  Osteoarthritis Cartilage       Date:  2014-07-17       Impact factor: 6.576

4.  Inhibition of inflammatory actions of aminobisphosphonates by dichloromethylene bisphosphonate, a non-aminobisphosphonate.

Authors:  Y Endo; M Shibazaki; K Yamaguchi; M Nakamura; H Kosugi
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

5.  Bisphosphonamidate clodronate prodrug exhibits selective cytotoxic activity against melanoma cell lines.

Authors:  Marie R Webster; Chandrashekhar Kamat; Nick Connis; Ming Zhao; Ashani T Weeraratna; Michelle A Rudek; Christine L Hann; Caren L Freel Meyers
Journal:  Mol Cancer Ther       Date:  2013-12-05       Impact factor: 6.261

6.  Clodronate acts on human osteoclastic cell proliferation, differentiation and function in a bioreversible manner.

Authors:  Raffaella Recenti; Giuseppe Leone; Lisa Simi; Marco Orfei; Pamela Pinzani; Giuseppe Pieraccini; Gloriano Moneti; Anna Maria Carossino; Alessandro Franchi; Gianluca Bartolucci; Silvia Carbonell Sala; Mauro Ginanneschi; Annalisa Tanini; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2007-05

7.  Pharmacokinetic profile of bisphosphonates in the treatment of metabolic bone disorders.

Authors:  Luigi Sinigaglia; Massimo Varenna; Silvia Casari
Journal:  Clin Cases Miner Bone Metab       Date:  2007-01

8.  A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates.

Authors:  Hannu Mönkkönen; Seppo Auriola; Petri Lehenkari; Maarit Kellinsalmi; Ilmo E Hassinen; Jouko Vepsäläinen; Jukka Mönkkönen
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

Review 9.  Mechanism of action of bisphosphonates.

Authors:  Alfred A Reszka; Gideon A Rodan
Journal:  Curr Osteoporos Rep       Date:  2003-09       Impact factor: 5.096

10.  A LC-MS/MS method for the analysis of intracellular nucleoside triphosphate levels.

Authors:  Ping Chen; Zhongfa Liu; Shujun Liu; Zhiliang Xie; Josephine Aimiuwu; Jiuxia Pang; Rebecca Klisovic; William Blum; Michael R Grever; Guido Marcucci; Kenneth K Chan
Journal:  Pharm Res       Date:  2009-03-17       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.